Solventum logged a 5.8% change during today's afternoon session, and is now trading at a price of $52.93 per share. The S&P 500 index moved -1.0%. SOLV's trading volume is 1,729,620 compared to the stock's average volume of 1,893,639.
Solventum trades -8.74% away from its average analyst target price of $58.0 per share. The 4 analysts following the stock have set target prices ranging from $48.0 to $69.0, and on average have given Solventum a rating of hold.
Anyone interested in buying SOLV should be aware of the facts below:
-
Solventum has moved -27.6% over the last year, and the S&P 500 logged a change of 24.1%
-
Based on its trailing earnings per share of 3.68, Solventum has a trailing 12 month Price to Earnings (P/E) ratio of 14.4 while the S&P 500 average is None
-
SOLV has a forward P/E ratio of 9.6 based on its forward 12 month price to earnings (EPS) of $5.51 per share
-
Its Price to Book (P/B) ratio is 2.37 compared to its sector average of None
-
Solventum Corporation, a healthcare company, engages in the developing, manufacturing, and commercializing a portfolio of solutions to address critical customer and patient needs.
-
Based in Saint Paul, the company has 22,000 full time employees and a market cap of $9.14 Billion.